CD99 acts as an upstream regulator of the PTPN12-mediated negative feedback loop for regulating ligand-induced dimerization or oligomerization of plasma membrane protein kinases, which are involved in tumor development and progression. The gene discussed is CD99; the disease is neoplasm.